Trials / Completed
CompletedNCT03580473
Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification
Phase II, National, Multicenter, Randomized, Double Blind Clinical Trial, to Evaluate the Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of Saturno II association on the control of ocular inflammation post-phacoemulsification
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SATURNO II association | opthalmic solution, 4 times a day |
| DRUG | Vigadexa® | opthalmic solution, 4 times a day |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2021-11-30
- Completion
- 2022-03-01
- First posted
- 2018-07-09
- Last updated
- 2022-03-07
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03580473. Inclusion in this directory is not an endorsement.